Cargando…
Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET
PURPOSE: A general glucose metabolism pattern is observed in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis; however, it is unclear whether further subregional metabolic differences exist. Therefore, the present study aimed to conduct an in-depth exploration of the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102654/ https://www.ncbi.nlm.nih.gov/pubmed/37064193 http://dx.doi.org/10.3389/fneur.2023.1100760 |
_version_ | 1785025733480939520 |
---|---|
author | Wang, Kai Zhao, Xiaobin Yuan, Leilei Chen, Qian Wang, Qun Ai, Lin |
author_facet | Wang, Kai Zhao, Xiaobin Yuan, Leilei Chen, Qian Wang, Qun Ai, Lin |
author_sort | Wang, Kai |
collection | PubMed |
description | PURPOSE: A general glucose metabolism pattern is observed in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis; however, it is unclear whether further subregional metabolic differences exist. Therefore, the present study aimed to conduct an in-depth exploration of the features of glucose metabolism within specific brain areas using (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET). MATERIALS AND METHODS: This retrospective study enrolled thirteen patients confirmed with LGI1 antibody encephalitis who were admitted to Beijing Tiantan Hospital from June 2021 to September 2022. All patients underwent (18)F-FDG PET before initiating clinical treatment. Changes in glucose metabolism in specific brain areas were analyzed using Cortex ID software. The laterality of (18)F-FDG uptake was assessed, and differences in specific brain areas were compared using paired t-tests. RESULTS: Significant metabolic changes in at least one brain region in 11 out of 13 patients (84.6%) were revealed by semi-quantitative analysis (z-score > 2). A bilateral decrease in the (18)F-FDG metabolic pattern was revealed in almost all brain regions of interest; in contrast, a hypermetabolic pattern was observed in the medial temporal region, with mean z-scores of 1.75 ± 3.27 and 2.36 ± 5.90 on the left and right sides, respectively (p = 0.497). In the prefrontal and temporal lobes, (18)F-FDG metabolism was significantly lower in the lateral region than in the medial region on both sides. For the cingulate cortex, significant hypometabolism was also observed in the posterior part compared to the anterior counterpart on both the left (z-score: −1.20 ± 1.93 vs. −0.42 ± 1.18, respectively; p = 0.047) and right (z-score: −1.56 ± 1.96 vs. −0.33 ± 1.63, respectively; p = 0.001) sides. However, a significant difference in regional metabolism was observed only on the left side (p = 0.041). CONCLUSION: An asymmetric (18)F-FDG metabolic pattern exists in patients with anti-LGI1 encephalitis. Meanwhile, varied regional metabolic differences were revealed bilaterally in specific cerebral areas, which could be associated with the clinical manifestations. |
format | Online Article Text |
id | pubmed-10102654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101026542023-04-15 Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET Wang, Kai Zhao, Xiaobin Yuan, Leilei Chen, Qian Wang, Qun Ai, Lin Front Neurol Neurology PURPOSE: A general glucose metabolism pattern is observed in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis; however, it is unclear whether further subregional metabolic differences exist. Therefore, the present study aimed to conduct an in-depth exploration of the features of glucose metabolism within specific brain areas using (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET). MATERIALS AND METHODS: This retrospective study enrolled thirteen patients confirmed with LGI1 antibody encephalitis who were admitted to Beijing Tiantan Hospital from June 2021 to September 2022. All patients underwent (18)F-FDG PET before initiating clinical treatment. Changes in glucose metabolism in specific brain areas were analyzed using Cortex ID software. The laterality of (18)F-FDG uptake was assessed, and differences in specific brain areas were compared using paired t-tests. RESULTS: Significant metabolic changes in at least one brain region in 11 out of 13 patients (84.6%) were revealed by semi-quantitative analysis (z-score > 2). A bilateral decrease in the (18)F-FDG metabolic pattern was revealed in almost all brain regions of interest; in contrast, a hypermetabolic pattern was observed in the medial temporal region, with mean z-scores of 1.75 ± 3.27 and 2.36 ± 5.90 on the left and right sides, respectively (p = 0.497). In the prefrontal and temporal lobes, (18)F-FDG metabolism was significantly lower in the lateral region than in the medial region on both sides. For the cingulate cortex, significant hypometabolism was also observed in the posterior part compared to the anterior counterpart on both the left (z-score: −1.20 ± 1.93 vs. −0.42 ± 1.18, respectively; p = 0.047) and right (z-score: −1.56 ± 1.96 vs. −0.33 ± 1.63, respectively; p = 0.001) sides. However, a significant difference in regional metabolism was observed only on the left side (p = 0.041). CONCLUSION: An asymmetric (18)F-FDG metabolic pattern exists in patients with anti-LGI1 encephalitis. Meanwhile, varied regional metabolic differences were revealed bilaterally in specific cerebral areas, which could be associated with the clinical manifestations. Frontiers Media S.A. 2023-03-31 /pmc/articles/PMC10102654/ /pubmed/37064193 http://dx.doi.org/10.3389/fneur.2023.1100760 Text en Copyright © 2023 Wang, Zhao, Yuan, Chen, Wang and Ai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Wang, Kai Zhao, Xiaobin Yuan, Leilei Chen, Qian Wang, Qun Ai, Lin Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title | Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title_full | Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title_fullStr | Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title_full_unstemmed | Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title_short | Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET |
title_sort | cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)f-fdg pet |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102654/ https://www.ncbi.nlm.nih.gov/pubmed/37064193 http://dx.doi.org/10.3389/fneur.2023.1100760 |
work_keys_str_mv | AT wangkai corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet AT zhaoxiaobin corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet AT yuanleilei corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet AT chenqian corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet AT wangqun corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet AT ailin corticalmetaboliccharacteristicsofantileucinerichgliomainactivated1antibodyencephalitisbasedon18ffdgpet |